Templates
91 results
Applied filters
Emtricitabine/tenofovir and raltegravir tablets for HIV PEP
2 February 2026SPS PGD template for the supply of emtricitabine/tenofovir disoproxil and raltegravir tablets for HIV Post Exposure Prophylaxis (HIV PEP).
Understanding and managing the risks associated with handling monoclonal antibodies (mAb)
29 January 2026A systematic approach to occupational risk assessment informs decisions about safe working practices with monoclonal antibodies (mAb)
Varenicline for smoking cessation
21 January 2026SPS PGD template for supply of varenicline to support smoking cessation in specified individuals.
Cytisinicline for smoking cessation
21 January 2026SPS PGD template for supply of cytisinicline to support smoking cessation in specified individuals.
Nitrofurantoin for Urinary Tract Infection (UTI)
2 January 2026SPS PGD template for the supply of nitrofurantoin capsules/tablets for the treatment of Urinary Tract Infection (UTI).
Aspirin tablets for use within antenatal and maternity services
18 December 2025SPS PGD template for the supply of aspirin tablets to individuals at risk of pre-eclampsia during pregnancy.
Podophyllotoxin (topical) for external anogenital warts
17 December 2025SPS PGD template for the supply of podophyllotoxin 0.15% w/w cream or 0.5% w/v solution for the treatment of external anogenital warts.
Imiquimod 5% w/w cream for anogenital warts
17 December 2025SPS PGD template for the supply of imiquimod 5% w/w cream for the treatment of external anogenital warts.
Emtricitabine and tenofovir alafenamide (TAF) tablets as PrEP
5 December 2025SPS PGD template for the supply of emtricitabine and tenofovir alafenamide (TAF) tablets as Pre-Exposure Prophylaxis (PrEP) for the prevention of HIV infection.
Co-amoxiclav for human and animal bites
27 November 2025SPS PGD template for supply of co-amoxiclav for the prophylaxis of human and animal bites in specified patient groups.